Publicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (7)

2024

  1. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

2021

  1. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

    Molecular Oncology, Vol. 15, Núm. 12, pp. 3691-3705

  2. Mutational characterization of cutaneous melanoma supports divergent pathways model for melanoma development

    Cancers, Vol. 13, Núm. 20

2020

  1. Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

    The Lancet Oncology, Vol. 21, Núm. 3, pp. 456-466

2013

  1. High stability of microRNAs in tissue samples of compromised quality

    Virchows Archiv, Vol. 463, Núm. 6, pp. 765-774

  2. rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility

    PLoS ONE, Vol. 8, Núm. 3

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4